DELRAY BEACH, Fla. , Oct. 4, 2024 /PRNewswire/ -- The global peritoneal dialysis market is set to grow from USD 9.
58 billion in 2024 to USD 12.70 billion by 2029, reflecting a robust CAGR of 5.8%.
This expansion is largely driven by the rising prevalence of chronic kidney disease (CKD), particularly among older populations, as well as a shift towards home-based treatment options. Notably, about 14% of U.S.
adults are affected by CKD, with significant government support for peritoneal dialysis in countries like China , enhancing accessibility. Key players such as Baxter International, Fresenius Medical Care, and Medtronic are advancing technologies to improve patient care, yet the market faces challenges like underutilization in low-income regions and a critical shortage of skilled nephrologists. Emerging economies like India and Brazil present significant growth opportunities, especially with increased healthcare expenditure.
The Asia Pacific region is anticipated to exhibit the highest growth, fueled by an aging population and enhanced healthcare accessibility initiatives. As the market evolves, innovations in dialysis equipment and telemedicine are likely to further improve patient management and treatment outcomes, positioning peritoneal dialysis as a pivotal component of kidney care..
